Avid Radiopharmaceuticals, Inc.
Novel imaging agent to detect amyloid plaque in patients with Alzheimer’s disease. Acquired in December 2010 by Eli Lilly and Company and approved by the FDA in 2012.
Exited Portfolio Company
Novel imaging agent to detect amyloid plaque in patients with Alzheimer’s disease. Acquired in December 2010 by Eli Lilly and Company and approved by the FDA in 2012.
Exited Portfolio Company